Nuclear ATR lysine-tyrosylation protects against heart failure by activating DNA damage response

Cell Rep. 2023 Apr 25;42(4):112400. doi: 10.1016/j.celrep.2023.112400. Epub 2023 Apr 17.

Abstract

Dysregulated amino acid increases the risk for heart failure (HF) via unclear mechanisms. Here, we find that increased plasma tyrosine and phenylalanine levels are associated with HF. Increasing tyrosine or phenylalanine by high-tyrosine or high-phenylalanine chow feeding exacerbates HF phenotypes in transverse aortic constriction and isoproterenol infusion mice models. Knocking down phenylalanine dehydrogenase abolishes the effect of phenylalanine, indicating that phenylalanine functions by converting to tyrosine. Mechanistically, tyrosyl-tRNA synthetase (YARS) binds to ataxia telangiectasia and Rad3-related gene (ATR), catalyzes lysine tyrosylation (K-Tyr) of ATR, and activates the DNA damage response (DDR) in the nucleus. Increased tyrosine inhibits the nuclear localization of YARS, inhibits the ATR-mediated DDR, accumulates DNA damage, and elevates cardiomyocyte apoptosis. Enhancing ATR K-Tyr by overexpressing YARS, restricting tyrosine, or supplementing tyrosinol, a structural analog of tyrosine, promotes YARS nuclear localization and alleviates HF in mice. Our findings implicate facilitating YARS nuclear translocation as a potential preventive and/or interfering measure against HF.

Keywords: ATR; CP: Molecular biology; DNA damage response; heart failure; protein tyrosylation; tyrosyl-tRNA synthetase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • DNA Damage
  • Heart Failure*
  • Lysine / genetics
  • Mice
  • Phenylalanine
  • Tyrosine / metabolism
  • Tyrosine-tRNA Ligase* / chemistry
  • Tyrosine-tRNA Ligase* / genetics
  • Tyrosine-tRNA Ligase* / metabolism

Substances

  • Ataxia Telangiectasia Mutated Proteins
  • Lysine
  • Phenylalanine
  • Tyrosine
  • Tyrosine-tRNA Ligase
  • Atr protein, mouse